4//SEC Filing
Goodrich Katherine 4
Accession 0001819790-25-000093
CIK 0001819790other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:05 PM ET
Size
7.9 KB
Accession
0001819790-25-000093
Insider Transaction Report
Form 4
Goodrich Katherine
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-12+4,540→ 4,540 totalExercise: $40.95Exp: 2035-06-11→ Common Stock (4,540 underlying) - Award
Restricted Stock Units
2025-06-12+2,954→ 2,954 total→ Common Stock (2,954 underlying)
Footnotes (3)
- [F1]Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
- [F3]RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0002044770
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 4:05 PM ET
- Size
- 7.9 KB